R&D Sponsored Organoid neurotoxicity testing gains momentum Organoid-based approaches may become an integral part of neurological safety testing, offering a clearer view of risk.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
R&D Changing how the world finds new medicines: Physics modellin... Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.
R&D The quiet evolution taking place in paediatric imaging In children, MRI is increasingly used for imaging of the central nervous system (CNS), chest, abdomen, pelvis and musculoskeletal tissue.
R&D DNA as a programmable language, with Adrian Woolfson and Kai... A new technology just announced this weekend in a paper in Nature could have a radical impact on how gene assembly is carried out.
R&D Simplicity wins: How Lean principles and smart automation ca... Manufacturers truly outperforming their peers share a defining trait: a ruthless commitment to simplicity, based on Lean principles and automation.
Digital Trustworthy and novel AI in clinical trial planning, with Kr... Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.